Search research articles
Contact Us
Filters
Showing results (121-130 of 195) with videos related to
Page
of 20
Sort By:
Inflammatory Bowel Diseases
|
October 18, 2018
Validation and Investigation of the Operating Characteristics of the Ulcerative Colitis Endoscopic Index of Severity
Djuna C de Jong, Mark Löwenberg, Ioannis Koumoutsos, et al.
Gastroenterology & Hepatology
|
October 1, 2011
Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group
Miles P Sparrow, Peter M Irving, Leonard Baidoo, et al.
Alimentary Pharmacology & Therapeutics
|
July 5, 2021
An observational study of switching infliximab biosimilar: no adverse impact on inflammatory bowel disease control or drug levels with first or second switch
Raphael P Luber, Rhona O'Neill, Sukhpreet Singh, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
June 6, 2022
Cyclin-dependent Kinase 9 as a Potential Target for Anti-TNF-resistant Inflammatory Bowel Disease
Omer S Omer, Arnulf Hertweck, Luke B Roberts, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 26, 2024
Efficacy and Safety of Upadacitinib for Perianal Fistulizing Crohn's Disease: A Post Hoc Analysis of 3 Phase 3 Trials
Jean-Frédéric Colombel, Ana P Lacerda, Peter M Irving, et al.
The New England Journal of Medicine
|
June 28, 2023
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Geert D'Haens, Marla Dubinsky, Taku Kobayashi, et al.
Inflammatory Bowel Diseases
|
April 4, 2025
Assessment and Impact of Age on the Safety and Efficacy of Etrasimod in Patients With Ulcerative Colitis: A Post Hoc Analysis of Data From the ELEVATE UC Clinical Program
Gary R Lichtenstein, Jessica R Allegretti, Edward V Loftus, et al.
Inflammatory Bowel Diseases
|
August 22, 2015
Prevalence and Risk Factors for Functional Vitamin B12 Deficiency in Patients with Crohn's Disease
Mark G Ward, Viraj C Kariyawasam, Sathis B Mogan, et al.
Science (New York, N.Y.)
|
September 14, 2023
Conserved γδ T cell selection by BTNL proteins limits progression of human inflammatory bowel disease
Robin J Dart, Iva Zlatareva, Pierre Vantourout, et al.
Journal of Crohn'S & Colitis
|
September 2, 2025
Faecal loss of vedolizumab is associated with UC severity, lower serum vedolizumab levels and rates of clinical response: Results from the FAVOUR study
Mark A Samaan, Georgina Cunningham, Samuel Hsiang Lim, et al.
Page
of 20
Search research articles
Search
Showing results (121-130 of 195) with videos related to
Sort By:
Page
of 20
Inflammatory Bowel Diseases
|
October 18, 2018
Validation and Investigation of the Operating Characteristics of the Ulcerative Colitis Endoscopic Index of Severity
Djuna C de Jong, Mark Löwenberg, Ioannis Koumoutsos, et al.
Gastroenterology & Hepatology
|
October 1, 2011
Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group
Miles P Sparrow, Peter M Irving, Leonard Baidoo, et al.
Alimentary Pharmacology & Therapeutics
|
July 5, 2021
An observational study of switching infliximab biosimilar: no adverse impact on inflammatory bowel disease control or drug levels with first or second switch
Raphael P Luber, Rhona O'Neill, Sukhpreet Singh, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
June 6, 2022
Cyclin-dependent Kinase 9 as a Potential Target for Anti-TNF-resistant Inflammatory Bowel Disease
Omer S Omer, Arnulf Hertweck, Luke B Roberts, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 26, 2024
Efficacy and Safety of Upadacitinib for Perianal Fistulizing Crohn's Disease: A Post Hoc Analysis of 3 Phase 3 Trials
Jean-Frédéric Colombel, Ana P Lacerda, Peter M Irving, et al.
The New England Journal of Medicine
|
June 28, 2023
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Geert D'Haens, Marla Dubinsky, Taku Kobayashi, et al.
Inflammatory Bowel Diseases
|
April 4, 2025
Assessment and Impact of Age on the Safety and Efficacy of Etrasimod in Patients With Ulcerative Colitis: A Post Hoc Analysis of Data From the ELEVATE UC Clinical Program
Gary R Lichtenstein, Jessica R Allegretti, Edward V Loftus, et al.
Inflammatory Bowel Diseases
|
August 22, 2015
Prevalence and Risk Factors for Functional Vitamin B12 Deficiency in Patients with Crohn's Disease
Mark G Ward, Viraj C Kariyawasam, Sathis B Mogan, et al.
Science (New York, N.Y.)
|
September 14, 2023
Conserved γδ T cell selection by BTNL proteins limits progression of human inflammatory bowel disease
Robin J Dart, Iva Zlatareva, Pierre Vantourout, et al.
Journal of Crohn'S & Colitis
|
September 2, 2025
Faecal loss of vedolizumab is associated with UC severity, lower serum vedolizumab levels and rates of clinical response: Results from the FAVOUR study
Mark A Samaan, Georgina Cunningham, Samuel Hsiang Lim, et al.
Page
of 20